10-K: U.S. Physical Therapy Reports Strong 2025 Growth, Strategic Alliances

U.S. Physical Therapy, Inc. reported significant revenue and profit growth in 2025, driven by strategic acquisitions and an expanding clinic network, alongside a dividend increase and new hospital alliances.

Summary

• Net revenue for 2025 increased by 16.3% to $781.0 million, up from $671.3 million in 2024.
• Net income attributable to USPH shareholders (GAAP) rose 26.0% to $39.6 million in 2025, compared to $31.4 million in 2024.
• Basic and diluted earnings per share (GAAP) were $1.42 for 2025, a decrease from $1.84 in 2024, primarily due to a $24.5 million revaluation of redeemable non-controlling interests.
• Adjusted EBITDA (non-GAAP) increased by 16.2% to $95.0 million in 2025 from $81.8 million in 2024.
• Operating Results (non-GAAP) increased by $3.1 million to $40.0 million in 2025, with Operating Results per share at $2.63.
• The company owned and/or managed 780 clinics in 44 states as of December 31, 2025, an increase from 761 clinics at the end of 2024.
• Total patient visits for physical therapy operations reached 6,150,104 in 2025, a 14.9% increase from 5,353,189 in 2024.
• The average net rate per patient visit increased to $105.76 in 2025 from $104.71 in 2024.
• The Board of Directors raised the quarterly dividend rate from $0.45 to $0.46 per share, effective for Q1 2026.
• The company repurchased 81,322 shares of common stock for $5.6 million in Q4 2025, with $19.4 million remaining under the authorized share repurchase program.
• Two 10-year strategic alliances with hospital systems were announced in February 2026, expected to be accretive to revenue, operating income, and margins.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, reflecting robust financial growth, strategic expansion through acquisitions and alliances, and a commitment to shareholder returns via increased dividends and share repurchases. The only notable negative is the GAAP EPS reduction due to non-cash revaluation, which is less concerning given the strong underlying operational performance.

Positives

• Net revenue increased by 16.3% to $781.0 million in 2025, demonstrating strong top-line growth.
• Net income attributable to USPH shareholders (GAAP) grew by 26.0% to $39.6 million in 2025.
• Adjusted EBITDA (non-GAAP) increased by 16.2% to $95.0 million, indicating improved operational profitability.
• Operating Results (non-GAAP) per share increased to $2.63 in 2025 from $2.45 in 2024.
• The company expanded its clinic network, operating 780 clinics in 44 states by December 31, 2025.
• Patient visits increased by 14.9% in 2025, reflecting higher demand for services.
• The net rate per patient visit improved to $105.76 in 2025, contributing to revenue growth.
• The Board of Directors increased the quarterly dividend rate from $0.45 to $0.46 per share, signaling confidence in future performance and commitment to shareholder returns.
• Strategic alliances with prominent hospital systems are expected to be accretive to revenue, operating income, and margins.
• The company repurchased $5.6 million of its common stock in Q4 2025, indicating a focus on enhancing shareholder value.

Negatives

• GAAP earnings per share decreased to $1.42 in 2025 from $1.84 in 2024, primarily due to a $24.5 million revaluation of redeemable non-controlling interests.
• Interest income from investments significantly decreased to $0.1 million in 2025 from $3.9 million in 2024, a 97.3% decline.
• Interest expense, debt and other, increased by 18.0% to $9.5 million in 2025 due to increased borrowings.
• The change in revaluation of put-right liability resulted in a net non-cash expense of $1.3 million in 2025, a substantial increase from $0.1 million in 2024.
• Corporate office costs increased by 18.8% to $69.3 million in 2025, outpacing net revenue growth as a percentage of revenue (8.9% in 2025 vs. 8.7% in 2024).

Risks

• Decreases in Medicare reimbursement rates may adversely affect financial results, despite an expected 1.75% increase for 2026, as historical rates have seen decreases.
• Revenue from Medicare and Medicaid is subject to potential retroactive reduction, post-payment audits, and recoupments, which could lead to significant fines and penalties.
• Dependence on third-party payors means changes in reimbursement rates or payment methods from commercial health insurers, HMOs, PPOs, and workers' compensation insurers could limit future revenue and profitability.
• Non-compliance with federal and state laws and regulations related to patient information privacy (HIPAA/HITECH), corporate practice of medicine, and fee-splitting could result in fines, penalties, exclusion from federal programs, and reputational harm.
• Competitive, economic, or reimbursement conditions may necessitate clinic reorganizations or closures, incurring losses and write-downs of goodwill and intangible assets.
• Termination of hospital affiliation arrangements could adversely impact revenue and results of operations.
• Future public health crises and epidemics/pandemics could disrupt operations, supply chains, lead to temporary loss of employees, and decline in patient appointments.
• Debt and financial obligations could adversely affect financial condition, ability to obtain future financing, and business operations, with loan agreements containing restrictive covenants.
• Certain acquisition agreements contain put-rights related to future purchases of significant equity interests, which are outside of the company's control and could require substantial capital.
• The ability to control variable interest entities (VIEs) through contractual arrangements may not be as effective as direct ownership, and conflicts of interest with equity holders could arise.
• Impact on business and cash reserves resulting from retirement or resignation of key partners and the resulting purchase of their non-controlling interests.
• Maintaining information technology systems with adequate safeguards to protect against cyber-attacks is crucial, as breaches could lead to legal action, reputational harm, and HIPAA/HITECH violations.
• Dependence on hiring, training, and retaining qualified employees, especially physical therapists, in a competitive labor market, which could lead to higher employment costs and reduced revenues.
• Fluctuations in revenues due to severe weather and other seasonal factors, particularly in states prone to snow, ice, hurricanes, and severe storms.
• Operating in a highly competitive industry with local, regional, and national entities, some with superior resources, could adversely affect business.
• Future acquisitions may use significant resources, be unsuccessful, and expose the company to unforeseen liabilities, including integration difficulties and potential loss of key employees.
• Employer and other contracted customers in the industrial injury prevention services business may terminate relationships on short notice, adversely affecting operating results.
• Use of emerging technologies, including artificial intelligence, involves inherent risks such as inaccurate results, cybersecurity, data privacy, compliance, ethical, and regulatory challenges.
• Failure to maintain effective internal control over financial reporting could lead to untimely or inaccurate financial reports, restatements, investigations, and loss of investor confidence.
• Issuance of shares in connection with financing transactions or under stock incentive plans will dilute current stockholders.
• Provisions in articles of incorporation and bylaws, such as blank check preferred stock and restrictions on special meetings, could delay or prevent a change in control.

Future Outlook

The company expects Medicare reimbursement for therapy services to increase by approximately 1.75% in 2026. It plans to continue the phased implementation of a new enterprise resource planning (ERP) system to enhance efficiency. The strategy includes ongoing acquisitions of outpatient physical therapy practices and industrial injury prevention services businesses, as well as developing satellite clinics and managing third-party owned clinics. Recently announced strategic alliances with hospital systems are anticipated to be accretive to revenue, operating income, and margins, with operations expected to begin in mid-2026 and full integration by year-end 2026.

Management Comments

• We are in the process of implementing a new enterprise resource planning (ERP) system designed to support certain human resources and accounting functions. The implementation is intended to enhance system integration, standardize processes, and improve operational efficiency and reporting capabilities.
• Our strategy is to continue acquiring outpatient physical therapy practices, develop outpatient physical therapy clinics as satellites in existing partnerships, manage outpatient physical therapy clinics owned by third parties, and continue acquiring companies that provide or serve the Company's industrial injury prevention services sector.
• We repurchased 81,322 of our own shares for total consideration of $5.6 million from the open market during the three months ended December 31, 2025, which demonstrates our focus on enhancing shareholder value as well as our confidence in the long-term prospects of the Company.
• These arrangements [strategic hospital alliances] will be accretive to our revenue, operating income and margins.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy, Inc.'s robust growth in 2025, particularly through strategic acquisitions and expansion of its clinic network, aligns with broader trends in the healthcare services sector emphasizing consolidation and integrated care delivery. The company's focus on both physical therapy and industrial injury prevention services positions it to capitalize on increasing demand for musculoskeletal care and employer-sponsored wellness programs. The announced strategic alliances with hospital systems reflect a growing industry trend towards partnerships that leverage specialized outpatient services within larger healthcare networks, aiming for improved patient access and cost efficiencies. The expected increase in Medicare reimbursement for therapy services in 2026, while modest, provides a more stable regulatory backdrop compared to previous years' decreases, which is a positive for the sector.

Comparison to Industry Standards

• U.S. Physical Therapy, Inc.'s 16.3% net revenue growth in 2025 significantly outpaces the average growth rates seen in the broader physical therapy industry, which typically ranges from 5-10% annually, indicating strong market penetration and successful acquisition strategy.
• The increase in average net rate per patient visit to $105.76 suggests effective revenue cycle management and favorable payor mix, potentially outperforming smaller, less diversified regional players who may struggle with negotiating power against large insurers.
• The company's aggressive acquisition strategy, adding 49 clinics in 2025 and 96 in 2024, demonstrates a higher pace of expansion compared to many competitors like ATI Physical Therapy or Select Medical, which also pursue growth but may have different integration challenges or market focuses.
• The dividend increase and share repurchase program indicate a stronger financial position and commitment to shareholder returns than many growth-focused healthcare providers who often prioritize reinvestment over direct shareholder distributions.

Management Changes

Corporate Governance

Legal Proceedings

• The company is a party to various legal actions, proceedings, claims, and governmental audits/investigations in the ordinary course of business.
• Potential outcomes include sanctions, damages, recoupments, fines, and other penalties.
• Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act, which can involve significant monetary damages and penalties.

Related Party Transactions

• The company leases two properties from Michael G. Mayrsohn, who is the President of Metro (a subsidiary) and was elected to the Board of Directors on May 20, 2025.
• Total lease payments of $0.5 million were made to Mr. Mayrsohn during 2025.
• Metro has made leasehold improvements valued at $0.3 million on these properties as of December 31, 2025.
• The total minimum future rental payments under these related party lease agreements is $2.6 million as of December 31, 2025.

Stakeholder Impact

• Shareholders benefit from increased dividends and share repurchases, indicating management's focus on returning capital and confidence in future performance.
• Employees are impacted by the company's growth strategy, which includes adding personnel and investing in training and development programs, along with competitive compensation and benefits.
• Customers (patients) benefit from an expanding network of physical therapy clinics and diversified services, potentially leading to improved access to care.
• Acquired partners and their employees are integrated into the company's structure, with provisions for non-controlling interests and employment agreements.
• Creditors are affected by the company's debt obligations and compliance with credit agreement covenants, which appear to be well-managed as of December 31, 2025.
• Hospital systems and employers benefit from strategic alliances and industrial injury prevention services, enhancing their clinical networks and employee wellness programs.

Next Steps

• Continue phased implementation of the new enterprise resource planning (ERP) system.
• Continue acquiring outpatient physical therapy practices and industrial injury prevention services businesses.
• Develop outpatient physical therapy clinics as satellites in existing partnerships.
• Manage outpatient physical therapy clinics owned by third parties.
• Begin operations for the strategic alliance with a New York hospital system in mid-2026, with all 60 clinics operational by year-end 2026.
• Integrate 10 outpatient physical therapy clinics into a local hospital system's clinical services network as part of a new strategic alliance.

Key Dates

Recommendation

U.S. Physical Therapy, Inc. demonstrates robust operational and financial performance, with significant revenue and adjusted EBITDA growth in 2025. The company's aggressive and successful acquisition strategy, coupled with expanding patient visits and an increasing net rate per visit, points to strong underlying business momentum. The recent dividend increase and share repurchase program underscore management's confidence and commitment to shareholder value. While GAAP EPS saw a non-cash reduction due to revaluation of non-controlling interests, the core operating results are highly favorable. Strategic alliances with hospital systems are expected to further boost future revenue and margins. These factors collectively present a compelling investment case for continued growth and shareholder returns, warranting a 'strong buy' recommendation.

Keywords

Physical Therapy, Industrial Injury Prevention, Healthcare Services, SEC Filing, 10-K, USPH, Outpatient Rehabilitation, Medicare Reimbursement, Acquisitions, Dividend, Share Repurchase, Corporate Governance, Cybersecurity, Financial Performance, Strategic Alliances